Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2217-2226
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2217
Table 1 Baseline characteristics of acute coronary syndrome study patients
All patientsPatients with
zP-value
RSR > 1RSR < 1
Baseline characteristics
Age, mean ± SD, yr61.56 ± 9.4260.9 ± 11.3662.22 ± 10.40-0.7060.001
Sex, Male/Female830/466255/109575/3570.002
Laboratory finding
TG, mg/dL141.69 ± 81.30139.30 ± 75.97143.71 ± 85.52-0.1950.232
CHOL, mg/dL173.71 ± 72.40173.00 ± 70.72174.30 ± 74.18-0.1560.286
HDL, mg/dL34.44 ± 9.1334.14 ± 9.2334.44 ± 9.14-0.0570.398
LDL, mg/dL108.75 ± 50.88108.97 ± 50.91108.56 ± 50.87-0.4040.065
LVEF, %52.29 ± 14.2741.17 ± 10.4154.30 ± 11.48-6.7040.001
GS37.88 ± 36.748.39 ± 36.4429.74 ± 37.56-7.5490.001
cTn 1, ng/mL1.86 ± 3.921.19 ± 1.840.42 ± 0.81-7.1480.001
cTn 25.02 ± 4.615.92 ± 6.122.43 ± 3.81-8.1010.001
cTn 311.81 ± 12.319.49 ± 12.744.57 ± 7.72-7.3610.001
BS, mg/dL137.31 ± 60.49136.94 ± 64.19135.02 ± 63.44-0.7180.526
WBC, 103/μL10.17 ± 3.319.89 ± 3.2510.64 ± 3.82-0.3820.247
MCV, fL88.23 ± 7.3288.92 ± 7.4288.48 ± 7.60-0.2490.642
MCH, pg29.31 ± 2.3129.43 ± 2.4129.62 ± 2.38-0.2620.342
MCHC, g/dL32.92 ± 0.8132.96 ± 0.7932.63 ± 0.72-0.5930.329
RDW, %14.48 ± 2.1215.42 ± 1.8214.92 ± 2.48-7.2540.001
MPV, fL8.53 ± 1.3610.48 ± 3.478.96 ± 2.24-2.8230.019
Neu, %6.25 ± 3.567.42 ± 1.446.82 ± 2.31-14.7620.001
Lymph, %2.13 ± 1.122.32 ± 1.212.02 ± 1.19-0.6670.422